Occlusive personal care composition

US9861562B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9861562-B2
Application numberUS-201514971448-A
CountryUS
Kind codeB2
Filing dateDec 16, 2015
Priority dateDec 16, 2015
Publication dateJan 9, 2018
Grant dateJan 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein, are compositions comprising a soluble quaternary ammonium polymer/polyphosphate complex made by combining ingredients comprising a quaternary ammonium polymer and polyphosphates having 2 or more phosphate units. Methods of making and using these compositions are also described.

First claim

Opening claim text (preview).

The invention claimed is: 1. A personal care composition, comprising: a soluble quaternary ammonium polymer polyphosphate complex formed by combining: at least one quaternary ammonium polymer; and at least one polyphosphate having 2 or more phosphate units; and a solvent; wherein the personal care composition is at least one of an antiperspirant or a deodorant, and wherein the personal care composition comprises from 20% to 50% by weight of the at least one polyphosphate. 2. The personal care composition of claim 1 , wherein the at least one quaternary ammonium polymer is a poly(N-trialkylaminoalkyl)acrylamide. 3. The personal care composition of claim 1 , wherein the at least one quaternary ammonium polymer is polyacrylamidopropyltrimonium chloride. 4. The personal care composition of claim 3 , wherein the polyacrylamidopropyltrimonium chloride has a number average molecular weight greater than or equal to 100,000 daltons and less than or equal to 500,000 daltons. 5. The personal care composition of claim 1 , wherein the solvent is an aqueous solvent. 6. The personal care composition of claim 1 , wherein the at least one polyphosphate has 3 or more phosphate units. 7. The personal care composition of claim 6 , wherein the at least one polyphosphate has greater than or equal to 6 phosphate units and less than or equal to 50 phosphate units. 8. The personal care composition of claim 1 , wherein the at least one polyphosphate comprises sodium tripolyphosphate. 9. The personal care composition of claim 1 , wherein the at least one polyphosphate comprises sodium polymetaphosphate. 10. The personal care composition of claim 1 , wherein the personal care composition is substantially free of aluminum complexes, or is substantially free of zirconium complexes, or is substantially free of both aluminum and zirconium complexes. 11. A method of occluding pores of a subject, the method comprising: applying the personal care composition of claim 1 to skin of the subject. 12. The personal care composition of claim 6 , wherein the at least one polyphosphate has about 23 phosphate units. 13. The personal care composition of claim 1 , wherein the at least one quaternary ammonium polymer is a poly(N-trialkylaminoalkyl)acrylamide, and wherein the at least one polyphosphate has greater than or equal to 6 phosphate units and less than or equal to 50 phosphate units. 14. The personal care composition of claim 13 , wherein the at least one quaternary ammonium polymer is polyacrylamidopropyltrimonium chloride. 15. The personal care composition of claim 13 , wherein the at least one polyphosphate comprises sodium polymetaphosphate. 16. The personal care composition of claim 14 , wherein the at least one polyphosphate comprises sodium polymetaphosphate. 17. The personal care composition of claim 1 , wherein the solvent is a non-aqueous solvent. 18. A personal care composition, comprising: a soluble quaternary ammonium polymer polyphosphate complex formed by combining in a solvent: at least one quaternary ammonium polymer; and at least one polyphosphate having 2 or more phosphate units; wherein the personal care composition comprises from 20% to 50% by weight of the at least one polyphosphate, and wherein the personal care composition is a cosmetic. 19. The personal care composition of claim 18 , wherein the solvent is an aqueous solvent. 20. The personal care composition of claim 1 , wherein the antiperspirant or deodorant further comprises a carrier in the form of a stick, a gel, a roll on, or an aerosol.

Assignees

Inventors

Classifications

  • Anti-perspirants or body deodorants (deodorisation of air A61L9/00) · CPC title

  • Mixtures of surface active compounds · CPC title

  • A61K8/24Primary

    Phosphorous; Compounds thereof · CPC title

  • Characterized by the absence of a particular group of ingredients · CPC title

  • Polyamides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9861562B2 cover?
Described herein, are compositions comprising a soluble quaternary ammonium polymer/polyphosphate complex made by combining ingredients comprising a quaternary ammonium polymer and polyphosphates having 2 or more phosphate units. Methods of making and using these compositions are also described.
Who is the assignee on this patent?
Colgate Palmolive Co
What technology area does this patent fall under?
Primary CPC classification A61K8/24. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).